Abstract: A closure member (e.g., door) stop includes a base having a top portion opposite a bottom portion, the bottom portion being configured for affixing to an installation point associated with the closure member, a flexure extending away from the top portion, a cushion comprising an angled face and an impact face, the impact face being configured to interface with the closure member during closing of the closure member, and the angled face being configured to interface with the closure member during opening of the closure member. The flexure provides an operable, bendable connection between the cushion and the base. Also, a lever is operably connected to the cushion and the flexure and configured to move the cushion away from a swing path of the closure member. The cushion extends into a swing path of the closure member when the closure member stop is at rest in the installed position.

Abstract: A closure member (e.g., door) stop includes a base having a top portion opposite a bottom portion, the bottom portion being configured for affixing to an installation point associated with the closure member, a flexure extending away from the top portion, a cushion comprising an angled face and an impact face, the impact face being configured to interface with the closure member during closing of the closure member, and the angled face being configured to interface with the closure member during opening of the closure member. The flexure provides an operable, bendable connection between the cushion and the base. Also, a lever is operably connected to the cushion and the flexure and configured to move the cushion away from a swing path of the closure member. The cushion extends into a swing path of the closure member when the closure member stop is at rest in the installed position.

Abstract: A system and method for using a plurality of micro-beads that possess multiple flavor layers to provide a user of a smoking article a plurality of flavors that change as the flavor layers are exhausted throughout the smoking experience. When an aerosol flows over the plurality of micro-beads, the outermost flavor layer of each respective micro-bead mixes with the drawn in aerosol and is brought to the user to create a distinct, but flavor layer specific, aerosol. Further provided is the individual micro-bead compartment being attached to a reservoir of liquid that is able to be heated, vaporized, and moved through the compartment.

Abstract: Provided herein is an electronic display assembly for use with a housing as well as a method for assembling an electronic display assembly within a housing. The assembly preferably contains an electronic display module having an electronic display secured within a mounting frame having a top and bottom surface. Top brackets and bottom brackets may be secured to the mounting frame and then secured to the interior of the housing. A front glass assembly can also be secured to the brackets. In some embodiments the housing may contain interior hangers which correspond to hangers that are fastened to the mounting frame of the electronic display module.

Abstract: The invention is the use of low boiling point, low vapor pressure blowing agents with froth polyurethane or polyisocyanurate foams to fill cavity voids when compared to higher vapor pressure or more ozone-depleting blowing agents.

Abstract: The invention described herein generally pertains to the use of low boiling point, low vapor pressure blowing agents with froth polyurethane or polyisocyanurate foams to achieve superior cavity filling than when using conventional higher vapor pressure or more ozone-depleting blowing agents.

Abstract: The invention provides a membrane comprising a gel reinforced by a support. The membrane has opposing surfaces and a thickness between said surfaces. The gel communicates between the opposing surfaces and allows diffusion of a nutrient solution through the membrane. A bioreactor is also provided, comprising a membrane-supporting structure, and a membrane according to the invention supported on the membrane-supporting structure.

Abstract: A process for cost-effectively and rapidly insulating a desired surface with spray foam insulation is described which includes the application of a polyurethane foam dispensed through heated conduits into a dispensing gun having a nozzle with essentially planar divergent lips having a triangular prism opening, the lips of the nozzle diverging at an angle of between about 5 and 35° inclusive, more preferably between 8 to 15° inclusive, most preferably 10 to 12° inclusive, thereby achieving application rates which are in excess of 70 Ft2/min, and optimally in excess of 100 Ft2/min.

Abstract: A parachute having radial slots distributed at regular intervals around the shoulder region to effect boundary flow separation, causing Von Karmen Vortex Street shed vortices to separate in a symmetrical manner from the inflated shape and resulting in an extremely stable aerodynamic decelerator. In addition, pressure vents in the crown region vent high pressure air during the inflation process to contribute to opening load control. Once the parachute is fully inflated, the pressure vents provide energetic airflow that ensures that the shed vortices created by the radial slots do not re-contact the canopy and cause instability.

Abstract: The invention relates generally to a stable flexible latex foam. The latex foam will contain at least one polymer having a plurality of hard domains and a plurality of soft domains, a micelle forming agent, a hydrocarbon propellant substantially free of dimethyl ether, and an agent which is a solvent for said micelle forming agent and an emulsifier for said hydrocarbon propellant.

Abstract: There is provided a container for a medicament powder formed from a material comprising a desiccant. In one embodiment the container is a medicament dispenser comprising a body defining a reservoir for medicament in powder form, and an outlet in communication with said reservoir. In another embodiment the container is a medicament dispenser comprising a body defining a chamber for receipt of a medicament carrier, and an outlet in communication with said chamber. Methods of controlling moisture flow are also described.

Abstract: The invention relates to the use of a ternary agent that is a sugar ester to inhibit or reduce chemical interaction between an active ingredient substance and a carrier in a solid pharmaceutical formulation, wherein the active ingredient substance is susceptible to chemical interaction with the carrier and the ternary agent. An inhalable solid pharmaceutical formulation comprising (a) an active ingredient substance susceptible to chemical interaction with lactose, (b) a carrier and (c) a ternary agent that is a sugar ester is also provided together with uses thereof and methods related thereto.

Abstract: A process for cost-effectively and rapidly insulating a desired surface with spray foam insulation is described which includes the application of a polyurethane foam dispensed through heated conduits into a dispensing gun having a nozzle with essentially planar divergent lips having a triangular prism opening, the lips of the nozzle diverging at an angle of between about 5 and 35° inclusive, more preferably between 8 to 15° inclusive, most preferably 10 to 12° inclusive, thereby achieving application rates which are in excess of 70 Ft2/min, and optimally in excess of 100 Ft2/min.

Abstract: A pharmaceutical aerosol formulation comprising (i) particulate medicament, (ii) 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3,-heptafluoro-n-propane or a mixture thereof as propellant, and (iii) 0.01 to 5% w/w based upon the propellant of a polar cosolvent, the particulate medicament being present in an amount from 0.005% to 5% w/w relative to the total weight of the formulation and having a particle size of less than 100 microns, and which formulation contains less than 0.0001% w/w surfactant based upon the weight of medicament.

Abstract: A pharmaceutical formulation comprising (i) one or more particulate medicaments, and (ii) 1,1,1,2-tetrafuoroethane as propellant, which formulation contains less than 0.0001% w/w surfactant based upon the weight of medicament, particulate medicament being present in an amount from 00005 to 5% w/w relative to the total weight of the formulation and having a particle size of less than 100 micrions, with the proviso that said medicament is other than salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate or a physiologically acceptable salt or solvate thereof and with the proviso that when said formulation consists of betamethasone, ergotamine tartrate or sodium cromoglycate and 1,1,1,2-tetrafluoroethane the weight to weight ratio of medicament to propellant is other than 69:7900 or 0.866% w/w.

Abstract: The invention relates to a solid pharmaceutical formulation comprising (a) an active ingredient substance susceptible to chemical interaction with lactose, (b) a carrier and (c) a ternary agent that is a sugar ester is also provided together with uses thereof and methods related thereto. The use of a ternary agent that is a sugar ester to inhibit or reduce chemical interaction between said active ingredient substance and a carrier in a solid pharmaceutical formulation, wherein the active ingredient substance is susceptible to chemical interaction with the carrier and the ternary agent is a sugar ester.

Abstract: The spinner bait blade is an elongated, flat strip having a twisted portion and a tail portion. The elongated twisted portion is twisted about its own longitudinal axis from a front to a back of the twisted portion. The tail comprises a continuation of the flat strip of material beyond the back of the twisted portion that extends at an angle away from the longitudinal axis. The spinner bait blade may be attached to a conventional spinner bait frame, or to an L-shaped frame. The speed of rotation when the blade is drawn through the water creates the illusion of solid, moving bait, and enables the lure to be used as a spinner bait, a buzz bait, or a surface popper.

Abstract: This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises particulate salbutamol and physiologically acceptable salts and solvates thereof and a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant, which formulation is substantially free of surfactant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.

Abstract: There is provided a medicament container or delivery device for use with medicament in dry powder form comprising a material that reduces the surface energy or increases the electrical conductivity of some or all parts of the medicament container or delivery device which come into contact with said dry powder form medicament. Suitably, the material has friction-reducing or electrical conductivity-enhancing properties.